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ABSTRACT 
 
Methods for tracheal repair and regeneration are necessary due to the limitations 
of tracheal resection and reconstruction for certain disorders such as tracheal stenosis, 
tracheomalacia, and tracheal tumors. Additionally, pulmonary injuries such as airway 
burns do not have effective treatment options aside from supportive care. The feasibility 
of a cell spraying device is investigated here as a system for applying human bronchial 
epithelial cells (HBECs) to decellularized porcine trachea matrices for creation of 
engineered grafts or as a minimally invasive method for delivering cells for wound 
healing. 
HBECs show viability greater than 90% after spraying onto cell culture media or 
tissue culture plastic. Similarly, one day after spraying onto decellularized trachea, 
viabilities are seen to be around 90%. Around day three, viabilities were slightly 
decreased to around 80%. After culturing for over one week, HBECs sprayed onto 
decellularized trachea displayed a basal cell marker (cytokeratin-5, CK5) and a club cell 
marker (uteroglobin). Markers for ciliated cells and goblet cells that are crucial for 
tracheal epithelium could not be found, but this needs to be investigated further. To 
validate the mechanical performance of the decellularized trachea, compressive 
resistance testing was performed before and after decellularization of tracheal rings. 
Results were generally inconclusive with high degrees of variability. A paired sample test 
conducted with 4 tracheas provided the most interesting results and showed that the 
decellularization process produced a significantly different compressive resistance 
compared to the native samples. In practice though this did not seem to be noticeable as 
the variability found within tracheal samples masked the difference. This would suggest 
that the decellularization process is not detrimental to the compressive resistance of 
trachea rings. Based on the results reported here, using a cell spraying device for 
engineering tracheal grafts and airway epithelial repair seems achievable. 
  
iv 
 
Table of Contents 
 
Acknowledgments .......................................................................................................................... i 
Dedication ....................................................................................................................................... ii 
ABSTRACT ................................................................................................................................... iii 
Table of Contents ......................................................................................................................... iv 
List of Figures ............................................................................................................................... vi 
1. INTRODUCTION/BACKGROUND ......................................................................................... 1 
1.1 Trachea bioengineering ..................................................................................................... 1 
1.2 Cell spraying ........................................................................................................................ 6 
2. EXPERIMENTAL METHODS/MATERIALS ......................................................................... 8 
2.1 Cell culture ........................................................................................................................... 8 
2.2 Obtaining porcine trachea ................................................................................................. 8 
2.3 Decellularization of porcine tracheas .............................................................................. 9 
2.4 Seeding cells onto decellularized porcine trachea ........................................................ 9 
2.5 Spraying ............................................................................................................................. 10 
2.5.1 Sprayer setup ............................................................................................................. 10 
2.5.2 Trachea pieces in 24-well plate............................................................................... 10 
2.5.3 Intact trachea segment in upright bioreactor ......................................................... 11 
2.6 Culture and imaging ......................................................................................................... 11 
2.7 Quantification of cell viability ........................................................................................... 12 
2.8 Histology ............................................................................................................................ 12 
2.8.1 Freezing blocks .......................................................................................................... 12 
2.8.2 Sectioning ................................................................................................................... 12 
2.9 Immunofluorescent staining ............................................................................................ 13 
2.9.1 Cytokeratin 5 (CK5) .................................................................................................. 13 
v 
 
2.9.2 Uteroglobin ................................................................................................................. 13 
2.10 Mechanical testing.......................................................................................................... 14 
2.11 Statistical analysis .......................................................................................................... 14 
3. RESULTS ................................................................................................................................. 15 
3.1 Compressive resistance mechanical testing of native vs. decellularized porcine 
trachea ...................................................................................................................................... 15 
3.2 HBECs maintain high viability after spraying onto multiple types of substrates ..... 17 
3.3 Seeding of HBECs onto decellularized trachea pieces .............................................. 18 
3.4 Successful application of HBECs onto decellularized tracheal pieces using sprayer 
device ........................................................................................................................................ 21 
3.5 Sprayed HBECs on trachea pieces express lung epithelial cell markers ................ 22 
3.6 Spraying onto intact trachea using a vertical mini-bioreactor .................................... 23 
4. DISCUSSION .......................................................................................................................... 23 
4.1 Compressive mechanical testing of decellularized porcine trachea is inconclusive
 ................................................................................................................................................... 23 
4.2 Sprayer can be used for cell deposition onto multiple substrates without adversely 
affecting cell viability ............................................................................................................... 25 
4.3 Troubleshooting of HBEC seeding onto trachea ......................................................... 26 
4.4 Sprayer can be used to deliver bronchial epithelial cells onto decellularized 
trachea ...................................................................................................................................... 28 
4.5 Considerations for spraying cells in a clinically relevant setting................................ 29 
4.6 HBECs maintain at least two epithelial cell markers after spraying.......................... 31 
5. CONCLUSION ........................................................................................................................ 32 
6. Bibliography ............................................................................................................................. 59 
  
vi 
 
List of Figures 
 
Figure 2.1 – Images of sprayer setup. ..................................................................................... 33 
Figure 2.2 – Image of mini-bioreactor setup. .......................................................................... 34 
Figure 2.3 – Images of compressive mechanical testing. ..................................................... 34 
Figure 3.1 – Trachea ring compression with small indenter and 2 cm rings. .................... 35 
Figure 3.2 – Trachea ring compression by location (proximal to distal) with small indenter 
and 1 cm rings. ............................................................................................................................ 36 
Figure 3.3 – Data from Figure 3.2 averaged by treatment group (native vs. 
decellularized). ............................................................................................................................. 37 
Figure 3.4 – Trachea ring compression by location (proximal to distal) with large indenter 
and APIC trachea. ....................................................................................................................... 38 
Figure 3.5 – Data from Figure 3.4 averaged by treatment group (native vs. 
decellularized). ............................................................................................................................. 39 
Figure 3.6 – Trachea ring compression by location (proximal to distal) with large indenter 
and Hormel tracheas. ................................................................................................................. 40 
Figure 3.7 – Data from Figure 3.6 averaged by treatment group (native vs. 
decellularized). ............................................................................................................................. 41 
Figure 3.8 – Data from paired samples experiment averaged by treatment group for 
each trachea. ............................................................................................................................... 42 
Figure 3.9 – Mean difference in compressive resistance after decellularization. .............. 43 
Figure 3.10 – Representative LIVE/DEAD staining images of spraying HBECs into 
media. ........................................................................................................................................... 44 
Figure 3.11 – Cell viability one day after spraying into media. ............................................. 45 
Figure 3.12 – HBEC viability one hour after spraying onto trachea, media, and empty 
well. ............................................................................................................................................... 46 
Figure 3.13 – Representative  LIVE/DEAD staining images of HBECs pipette-seeded on 
decellularized trachea pieces at different seeding densities. ............................................... 46 
Figure 3.14 – LIVE/DEAD staining images of HBECs, FBs, and A549s pipette-seeded 
onto decellularized trachea pieces. .......................................................................................... 47 
Figure 3.15 – Decellularized trachea seeding and co-culture assay over one day. ......... 48 
Figure 3.16 – Representative LIVE/DEAD staining images of supplementing media with 
FBS or PLTMax after seeding and culturing cells in tissue-conditioned media. ............... 49 
vii 
 
Figure 3.17 – Storing decellularized trachea in pen-strep prior to HBEC seeding via 
pipetting. ....................................................................................................................................... 50 
Figure 3.18 – Spraying HBECs onto decellularized trachea pieces (8 day). ..................... 51 
Figure 3.19 – Spraying HBECs onto decellularized trachea pieces (6 day). ..................... 52 
Figure 3.20 – HBEC viability for spray experiment #1 (3 day). ............................................ 53 
Figure 3.21 – HBEC viability for spray experiment #2 (8 day). ............................................ 54 
Figure 3.22 – HBEC viability for spray experiment #3 (6 day). ............................................ 55 
Figure 3.23 – Representative H&E staining images of sprayed trachea samples at day 9.
 ....................................................................................................................................................... 56 
Figure 3.24 – Representative CK5 immunofluorescent staining images of sprayed 
trachea samples at day 8. .......................................................................................................... 57 
Figure 3.25 – Representative uteroglobin immunofluorescent staining images of sprayed 
trachea samples at day 8. .......................................................................................................... 58 
  
1 
 
1. INTRODUCTION/BACKGROUND 
 
1.1 Trachea bioengineering 
 
To understand how to bioengineer a trachea we must first know the necessary 
anatomy and physiology. The trachea is the main airway that conducts all the air we 
breathe to and from both lungs1. It is vital to the function of the respiratory system and 
therefore our survival. The trachea has two primary functions: 1) transporting air in and 
out of the lungs for gas exchange and 2) trapping and removing foreign debris and 
pathogens found in the airways2,3. 
To properly conduct air, the trachea must remain open under the pressures of 
respiration4. It is a long, rigid tube made up of incomplete cartilage rings connected by a 
portion of smooth muscle at the posterior of the trachea1,3,4. This structure accomplishes 
two things: 1) stiff cartilage maintains an open airway and 2) smooth muscle allows for 
flexibility to change shape of the airway. The stiffness of the cartilage rings provides 
mechanical support by resisting collapse of the airway and maintaining airway patency.  
Without it, the transmural pressures caused by inspiration and expiration would lead to 
obstruction of the airway. 
The cartilage found in the trachea is known as hyaline cartilage. It is composed 
of chondrocytes found in lacunae surrounded by dense ECM2,5. Chondrocytes secrete 
the collagens and proteoglycans that make up cartilage and end up trapped in a space 
called the lacunae5,6. Collagen provides the tensile properties seen in the trachea by 
having aligned fibers circumferentially and longitudinally on the lumenal and ablumenal 
surfaces5. This creates resistance to bending/collapse during periods of forced 
respiration and allows for longitudinal flexibility which is important for head and neck 
movement4,5. Proteoglycans confer the observed compressive resistance of cartilage 
because of their large, negatively charged glycosaminoglycan (GAG) side chains and 
the ability to swell up with water4,6. The water contained by the proteoglycans also 
produces the viscoelastic properties observed in the trachea7. Chondrocytes additionally 
produce enzymes (e.g. matrix metalloproteinases) which are able to break down 
extracellular matrix (ECM) proteins in order to remodel and renew the cartilage. 
Compared to other tissues, cartilage is sparsely populated with cells, which limits the 
need for abundant vasculature. 
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The smooth muscle connecting the cartilage known as the trachealis changes 
the shape of the trachea during respiration. This is especially important for physiological 
events such as coughing which require forced expiration and therefore a sudden change 
in the shape of the trachea1,4. Nerves that connect to the trachealis can also allow for 
response to altered breathing rates. Additionally, the trachealis is necessary to 
accommodate the passage of food through the esophagus which lies directly posterior to 
the trachea. 
Although the trachea is primarily composed of cartilage which has a limited blood 
supply, it has a complicated vasculature because of the epithelial cells found lining the 
inside of the airway. The main supply comes from arteries which travel longitudinally 
along both sides of the trachea1,3,8. Longitudinal arteries branch off into smaller vessels 
that travel circumferentially and meet medially around the trachea1,3,8. Due to the density 
of the cartilage, these arteries must travel between the cartilage rings where there is 
softer fibrous/connective tissue. The intercartilaginous arteries then supply a dense 
capillary bed found in the submucosal layer of the epithelium to nourish all the cells1,3,8. 
A crucial component of the trachea is the epithelium found in the airway. The 
tracheal epithelium is composed of multiple cell types and plays a central role trapping 
and removing foreign debris2,3,9. It is composed of three different cell types: 1. basal 
cells, 2. goblet cells, and 3. ciliated cells3,9. The basal cells are epithelial progenitors that 
have the potential to differentiate into both goblet cells and ciliated cells9,10. Research 
has shown that given proper cues – notably an air-liquid interface culture – basal cells 
can be differentiated in vitro9. Goblet cells, named because they resemble a wine goblet, 
are the cells that secrete mucus to cover the lumen of the trachea9. Mucus traps foreign 
particles and pathogens that can then be expelled from the body through coughing. 
Ciliated cells form cilia that beat rhythmically to move mucus produced in the lungs and 
trachea up the airway and out of the body1,2,9. This system is called the mucociliary 
escalator since the mucus is moved unidirectionally through a concerted motion by the 
cilia1,2. Together, the three types of cells form a pseudostratified ciliated columnar 
epithelium1,9,10. 
As mentioned above, one of the main functions of the trachea is predicated on its 
mechanical properties. Performing mechanical testing on native tracheal samples can 
provide information about the characteristics needed for an engineered trachea to 
perform its biological functions. The mechanical properties of engineered tissues are 
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vital to the seeding and maturation of cells during recellularization as well. It has been 
shown by multiple researchers that mechanical cues provided by the scaffold affect 
differentiation of cells and their behavior in the construct11–14. So these data could inform 
future research on producing mechanically similar scaffolds to native trachea to improve 
outcomes of engineered trachea. 
Clinical need for engineered tracheal constructs comes from multiple disorders, 
which cause large defects that cannot be repaired with existing tissue. These disorders 
include tracheal stenosis, tracheomalacia, and tracheal tumors3,4,15–17. Tracheal stenosis 
is a narrowing of the airway that can occur after tracheostomy or intubation in adults and 
children16. Congenital tracheal stenosis is a birth defect found in pediatric patients with 
the same narrowing. The narrowing can be life threatening as it severely restricts airflow. 
Tracheomalacia is a disorder where the tracheal cartilage is weakened causing a softer 
trachea which can lead to closure of the airway during respiration18. Tracheal tumors that 
are removed can also produce a large defect in the trachea4,15. Smaller defects (less 
than 3-4 cm) are typically treated by resection and anastomosing the ends of the 
remaining trachea15,19. Larger defects cannot be treated in this way due to the stress that 
would be created on the trachea and neck from anastomosing over such a long 
distance. In adults up to 50% of the trachea can be removed for a procedure while for 
children only 30% can be removed3,4. Additionally, data show that the rate of surgical 
failure increases as the length of trachea removed increases19. 
Large defects may be treated with organ transplantation. Typically, these are 
allografts where tissues are transplanted from another human. Allografts are not ideal 
because of the high risk of rejection after transplantation2,12,20,21. To prevent immune 
rejection these tissues need to be human leukocyte antigen (HLA) matched, but rarely 
are due to the shortage of donor organs and patients require lifelong 
immunosuppression12,14,17. For pediatric patients, allografts may be unsuitable because 
the donor trachea has to be the same size as the recipient trachea and donor tissues 
mainly come from adults. Even if a tracheal graft with the proper size is found, the graft 
has to be able to integrate with the adjacent tissue and grow with a pediatric patient2,16,17. 
This is why there is a need for engineered grafts that can be made quickly and bypasses 
using human donor tissue. 
A similar approach is using organs from another species to perform a 
xenotransplant. This method is useful because of the large supply of xenograft tissue 
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that can be obtained from other animals (particularly pigs)22. In the case of pigs, there is 
also lower risk of disease transmission due to the limited relatedness between pigs and 
humans23. Obviously, this method has serious concerns of rejection because of the 
foreign biological material present in the organs22–24. One way to circumvent this is 
genetically altering the animal to develop without certain immune-reactive antigens. For 
example, in pigs the alpha-gal antigen creates an acute immune response in humans. A 
strain of pig without this antigen has been created by modifying the DNA22–25. Another 
way to reduce the immune response is to use the animals like an “in vivo bioreactor” to 
produce human organs. This can be done using genetic engineering techniques where a 
blastocyst of a pig is created without a certain lineage or niche of cells like those that 
would produce the lung26. This missing niche can be replaced by human stem cells or 
progenitors and as the animal grows the human cells would grow into an adult organ26. 
The organ can then be used for transplant. There are many ethical concerns with this 
method, so it may not be implemented as a realistic solution. 
There are multiple approaches currently being used or studied to create trachea 
engineered grafts. One approach for developing tracheal grafts is bioprinting. This 
involves using biomaterials containing cells to 3D print a construct that can be implanted 
to replace or help regenerate tissue. This method is promising because it allows for 
careful spatial regulation of cells/growth factors or layering of different types of tissue. 
Furthermore, the size and shape of the construct can be customized to fit the needs of 
the patient. Unlike donor grafts, these constructs can be used for children who need an 
implant that grows with them2,16,17 or for cases that require a unique implant. The major 
concern with bioprinting is that the materials being used may not have the mechanical 
properties necessary to properly carry out tracheal functions. Typically these 
biomaterials are hydrogels that are not strong enough to maintain the patency of the 
airway. Synthetic polymers are often used for their superior strength, but they may not 
provide necessary extracellular cues for cells to properly regenerate the tissue. 
Another method is the use of animal or human organs that would otherwise be 
discarded and engineering them for organ donation. For example, organs from animals 
that are slaughtered for food would typically go to waste. Some human donor organs are 
also deemed unsuitable for transplant and go unused. These organs can be 
decellularized using various methods and then recellularized with human cells to create 
an organ for transplant. Proper decellularization protocols should remove as much of the 
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foreign cells and genetic material as possible while maintaining the protein composition 
and structure of the organ27,28. This produces a construct with limited immunoreactivity 
but conserves important ECM proteins. Retaining the scaffold/ECM of the native organ is 
advantageous because these proteins are highly conserved across mammals so they 
can provide important cues for the growth, migration, and maturation of cells21. 
One method of decellularization that has been shown to effectively remove 
cellular material while preserving ECM proteins is a chemical process using a series of 
osmotic agents, ionic/nonionic detergents, and enzymes. For decellularizing porcine 
trachea and lungs, the method involves rinsing with deionized (DI) water, Triton X-100 
(Triton), Sodium Deoxycholate (SDC), concentrated sodium chloride (NaCl), 
deoxyribonuclease (DNase), and then storage in phosphate buffered saline (PBS)29. 
After decellularization, scaffolds can be recellularized using multiple methods. 
The simplest method is static recellularization, which involves pipetting cells directly onto 
the scaffold and letting them attach with the help of gravity. For simple tissues with 
small, flat surfaces this may be suitable. However, many have pointed out that this 
strategy is ineffective for large, uneven surfaces and hollow/tubular organs30,31 – many 
tissues fall under at least one of these categories. Static seeding in these scenarios 
leads to dripping and pooling of cells which causes an uneven distribution of cells and 
potentially poor outcomes in tissue engineering applications. The size of the tissue/organ 
also plays a role into the choice of recellularization method since pipetting billions of 
cells into a lung, for example, would not be efficient. 
Alternatively, dynamic recellularization is the delivery of cells into a scaffold using 
a pump or bioreactor that continuously perfuses the cells throughout the decellularized 
scaffold. Theoretically, this allows for full coverage of cells in the construct and further 
may provide necessary mechanical stimuli for cells as they mature in the construct. For 
solid organs that contain many different cell types, there is a need for spatially-controlled 
delivery of cells. In pulmonary tissue engineering, this is where aerosol delivery of cells 
using a spraying device could be extremely useful similar to delivery of drugs into the 
lung via aerosol. 
Another area of clinical need is the management of inhalational injuries such as 
airway burns. Around 13,000 to 22,000 people get inhalational burns each year in the 
United States32. This leads to increased morbidity and mortality for patients and leads to 
worse outcomes when not treated properly33,34. A key component of inhalational injury is 
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loss of the airway epithelium which leads to inflammation and potential infection, airway 
obstruction, and stenosis33,34 . With supportive care, it takes about 3 weeks for the native 
epithelium to fully repair the damaged area33. By having a minimally invasive method to 
deliver epithelial cells to airway burn patients, the airway lining could be healed quickly 
and outcomes could be improved. Again, spray delivery of cells may be a solution. 
Although these disorders and subsequent procedures are relatively rare, 
developing improved methods for treatment would immensely help those patients who 
need it. The research performed in this thesis investigates the feasibility of using a spray 
device in trachea tissue engineering as a proof of concept for airway engineering and 
other pulmonary applications. 
 
1.2 Cell spraying 
 
An alternative method of seeding which has become increasingly studied is using 
a cell spraying device to deliver cells. Several researchers have used this approach for 
different applications including epidermal and burn wound healing31,35, intestinal 
epithelialization30, bladder regeneration using demucosalized colon36, and delivery of 
airway epithelial cells or MSCs for treatment of airway/lung injury37–39. The latter method 
is further studied here as a potential avenue for recellularization in pulmonary tissue 
engineering. Although airway epithelial cells and MSCs have been sprayed in vitro onto 
tissue culture plastic or biomaterial surfaces (gelatin) or in vivo into a rabbit model of 
airway injury, it has yet to be shown that airway epithelial cells can be sprayed onto 
decellularized trachea scaffolds as a method for airway engineering. By demonstrating 
this, use of cell spraying could be translated to recellularizing whole, decellularized 
porcine lungs. 
The sprayer is made with two flexible, plastic tubes that create an outer lumen 
and inner lumen. Compressed air is introduced through the inner tube and the liquid cell 
suspension is instilled through the outer lumen. Near the sprayer end, there is a short 
metal tube which is attached to the inner tubing and contains holes in the side. Liquid 
enters the inner lumen through these holes and is perturbed by the air. The disturbance 
in the liquid phase leads to a breakup of the flow into ligaments which further break up 
into droplets40. This interaction between the liquid and air creates an aerosolized spray 
outside the device. 
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The major benefit of using a cell sprayer is the ability to distribute cells across a 
large, contoured surface and inside of hollow, tubular organs30,31,35,37. Because of the 
cone-like shape of the spray pattern, this device should provide better coverage when 
reepithelializing airways compared to a static recellularization method. When combined 
with adhesive biomaterials, such as fibrin, pooling and dripping encountered with static 
seeding on unfavorable topographies can be overcome30,31,35,41. 
Another benefit for pulmonary applications is delivery of cells into proximal and 
distal areas of the lungs. The size of the device makes it possible to be used in smaller 
airways since it can be advanced down multiple generations of the bronchial tree. This is 
useful since a major issue with current recellularization approaches is the delivery of 
cells to distal parts of the airway to recapitulate the alveolar-capillary unit42. These areas 
are often difficult to access due to the narrowing of the bronchioles, which can easily 
lead to blockages. Others have also shown that this type of spraying device can be 
incorporated into an endoscopic device30,37,40. This would allow for targeted, on-demand 
application of cells during diagnostic and surgical procedures30. 
Spraying also affords spatial variability in cell distribution and layering of different 
cell types. This is important in pulmonary airway engineering since different areas of the 
lung have different compositions of cells in the epithelium. Using a sprayer, these 
cellular compositions could be matched along the airway tree. Spraying multiple layers 
of cells could recreate a pseudostratified epithelium that is characteristic of the airways. 
Aerosol deposition of cells is compatible with an air-liquid interface culture. This 
condition is important especially for the generation of functional airway grafts. Air-liquid 
interface is often used for differentiation of airway epithelial cells. Thiebes et al. have 
shown that respiratory epithelial cells can be sprayed onto transwell inserts and cultured 
in an air-liquid interface for 28 days producing goblet cells and ciliated cells37. 
There are potential applications for delivering soluble drugs (like pulmonary 
surfactant), cellular therapies, or growth factors to improve tissue engineering. The 
delivery of pulmonary surfactant has been studied as an application for newborns with 
respiratory distress syndrome43. Aerosol delivery is attractive in this scenario since the 
spraying device is small enough to be used in premature patients while also delivering 
the surfactant at a low pressure and low flow rate to limit trauma to the newborn. Cellular 
therapies for pulmonary alveolar proteinosis (PAP) or lung regeneration may also benefit 
from spray delivery of cells. PAP is caused by a defect present in macrophages of the 
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alveoli. Genetic correction of patient-derived macrophages44 or iPSC-derived 
macrophages45,46 can return the cells to a normal functional state. Spray delivery of 
these cells would allow for homogeneous distribution into the alveoli as a therapeutic for 
a diseased patient. Lung regeneration after injury has also been studied using sprayed 
MSCs as a cellular therapy39. 
Finally, the device could be used to seed cells onto completely different tissues 
like delivering endothelial cells to the lumenal surface of vascular grafts, or epithelial 
cells to the surface of the gastrointestinal tract. 
 
2. EXPERIMENTAL METHODS/MATERIALS 
 
2.1 Cell culture 
 
Human bronchial epithelial cells (HBECs) were obtained from Promocell 
(Heidelberg, Germany). Cells were cultured using Airway Epithelial Cell Growth Medium 
(Promocell). This was made by mixing Airway Epithelial Cell Growth Medium 
SupplementMix (C-39165, Promocell) with Airway Epithelial Cell Basal Medium (C-
21260, Promocell). The media was supplemented with 1 mL of Primocin (ant-pm-2, 
InvivoGen, San Diego, CA) as an antimicrobial agent. Cells were incubated at 37°C and 
5% CO2 with media being changed every 2-3 days. Cells were harvested for spraying by 
removing media, rinsing with PBS, and incubating with TrypLE Select (Thermo Fisher 
Scientific, Waltham, MA) to dissociate from culture flasks. Cell suspensions were 
centrifuged at 1200 rpm for 5 minutes. Subsequently, supernatants were aspirated being 
careful not to disturb the cell pellet. Cells were resuspended in growth media at a 
concentration of 1-5 million cells/mL prior to seeding and spraying experiments. 
A549s were obtained as a generous gift from the Daniel Vallera lab (University of 
Minnesota) and cultured with D10 media. Skin-derived fibroblasts were obtained as a 
generous gift from the Jakub Tolar lab (University of Minnesota) and grown with 
fibroblast media. RFP-positive HUVECs were obtained from Angio-Proteomie (Boston, 
MA) and grown using endothelial cell media from R&D Systems (Minneapolis, MN). 
 
2.2 Obtaining porcine trachea 
 
Porcine tracheas were obtained from the Visible Heart Lab (VHL, University of 
Minnesota, Minneapolis, MN), Advanced Preclinical Imaging Center (APIC, University of 
Minnesota), or Hormel Foods (Austin, MN). Connective tissue was removed from the 
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ablumenal side of the trachea. Tracheas were then either stored as native samples for 
use in mechanical testing or decellularized for use in spraying experiments and 
mechanical testing. Native trachea samples were stored in PBS at 4°C until use. 
 
2.3 Decellularization of porcine tracheas 
 
After removal of connective tissue, intact tracheas for decellularization were 
sequentially incubated with a series of reagents on a shaker plate. The trachea was 
incubated with approximately 500 mL of DI water overnight at 4°C. DI water was drained 
and the trachea was incubated with approximately 500 mL of 0.1% Triton X-100 (Sigma-
Aldrich, St. Louis, MO) for 24 hours at 4°C. Triton was drained and the trachea was 
incubated with approximately 500 mL of 2% SDC (D6750, Sigma-Aldrich) for 24-48 
hours at 4°C. Length of incubation for the SDC step was determined based on visual 
inspection of the trachea to assess degree of decellularization. SDC was drained and 
the trachea was rinsed with approximately 500 mL of concentrated (1 M) NaCl (S9625, 
Sigma-Aldrich) for 24 hours at 4°C. NaCl was drained and the trachea was rinsed with 
approximately 500 mL of 30 μg/mL bovine pancreatic DNase (10104159001, Roche 
Diagnostics, Indianapolis, IN) in 1.3 mM MgSO4 and 2 mM CaCl2 overnight at 4°C. 
Finally, the DNase solution was drained and samples were stored in 500 mL PBS at 
4°C. After discovering that contamination of the decellularized tissues was leading to cell 
death in seeding experiments, samples were stored in 500 mL PBS with 1x penicillin-
streptomycin (pen-strep) (15070-063, Thermo Fisher Scientific). This is discussed further 
in section 3.3. 
 
2.4 Seeding cells onto decellularized porcine trachea 
 
Decellularized porcine tracheas were cut into 1-2 cm wide rings. Rings were then 
cut open through the trachealis and 1-2 cm pieces were cut from cartilage rings. Trachea 
pieces were placed into wells of a 24-well plate and soaked in Airway Epithelial Cell 
Growth Medium overnight at 37°C. Before seeding, soaked trachea pieces were moved 
to empty wells of a new 24-well plate. Cell seeding was then performed by pipetting cell 
suspension directly onto the decellularized scaffold pieces. 
In certain experiments, fetal bovine serum (FBS, HyClone/GE Healthcare, 
Chicago, IL) and human platelet lysate (PLTMax, Mill Creek Life Sciences, Rochester, 
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MN) were used as 2% supplements to the cell culture medium or for incubating with the 
decellularized tissue overnight. 
In other experiments, collagen and fibronectin were used as coatings for the 
decellularized trachea scaffolds. Collagen, Type I solution from rat tail (C3867, Sigma-
Aldrich) was diluted with water for injection (WFI) to 0.01% (v/v). Human fibronectin 
(354008, Corning, Corning, NY) was diluted to 50 μg/mL with cell culture media. Tissues 
were incubated with approximately 250 μL of collagen or fibronectin at room temperature 
for 4 hours. Excess solution was aspirated and the tissue was rinsed with cell culture 
media prior to seeding. 
 
2.5 Spraying 
 
2.5.1 Sprayer setup 
 
A catheter-based spraying device (Abbe Vision, Minneapolis, MN) was 
connected to a syringe pump (Pump 11 Elite, Harvard Apparatus, Holliston, MA) and a 
generic airbrush compressor. The syringe pump was used for instilling the cell 
suspension into the outer lumen of the sprayer. The airbrush compressor was used to 
deliver air to the inner lumen of the sprayer. A HEPA filter was connected to the airbrush 
compressor to filter the air prior to its connection to the sprayer. Figure 2.1 shows 
images of the setup. 
 
2.5.2 Trachea pieces in 24-well plate 
 
Decellularized porcine tracheas were prepared as described in section 2.3 and 
2.4. Prior to spraying, 70% ethanol was run through the sprayer to clean it. Next, DI 
water was run through the sprayer to remove any residual ethanol. After the sprayer 
became clogged multiple times, it was determined that using ethanol to clean the 
sprayers was degrading the epoxy and creating blockages. From then on, only warm DI 
water was used to clean the sprayers. After cleaning, the sprayer was primed with cell 
suspension and preliminary sprays were performed without a substrate to obtain 
consistent sprays. Trachea pieces were then sprayed at a pressure of 30 psi using a 
volume of 100-250 μL to obtain a seeding density of 100,000-400,000 cells/cm2. To 
spray tracheal pieces, the air valve was first opened and the syringe pump was started 
as quickly as possible. After the spray volume was injected, the air valve was left open 
for approximately 5 seconds to spray residual volume of cell suspension. Then, the air 
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valve was closed, the sprayer was moved to the next sample, and the process repeated 
until all samples were sprayed. Cells sprayed into empty wells and cells dispensed 
through the sprayer (without air flow) were used as controls. 
 
2.5.3 Intact trachea segment in upright bioreactor 
 
To determine the feasibility of spraying in a clinically relevant setting, spraying 
was performed into upright trachea segments inside of a custom mini-bioreactor (Figure 
2.2). Mini-bioreactors were created using 35mm x 10mm tissue culture dishes (229635, 
CELLTREAT, Pepperell, MA) and 50 mL conical tubes (352070, Corning). Conical tubes 
were cut down to approximately 3 cm long using a handheld rotary tool kit. These pieces 
were attached to the bottom of the petri dish using Loctite Super Glue Gel Control 
(Henkel, Rocky Hill, CT). Super glue was allowed to dry overnight. Mini-bioreactors were 
gas sterilized prior to use. Decellularized porcine tracheas were cut into 2 cm long 
segments. Trachea segments were blotted using kimwipes to remove all excess 
moisture. Segments were attached to the bottom of the mini-bioreactors using 2% low 
melt agarose (E-3126-125, BioExpress, Kaysville, UT). Agarose was allowed to set for 1 
hour at room temperature to ensure attachment. 
Spraying was then performed in similar manner as described above. Lower 
volumes (50-100 μL) were used to limit pooling and dripping of the cell suspension in the 
bioreactor. Cell concentrations were increased to maintain the same seeding density as 
described above. In the final experiment, fibronectin was sprayed to coat the inside of 
the tracheal rings using the same concentration as described in section 2.4. 
 
2.6 Culture and imaging 
 
After spraying of cells, trachea pieces were moved into wells with 0.75-1 mL of 
growth media. This was done – rather than adding media directly on top of the sprayed 
pieces – to minimize washing away cells from the surface of the trachea. Media was 
changed 24 hours after spraying and subsequently every other day. Samples were 
imaged at multiple time points using the LIVE/DEAD viability/cytotoxicity kit (Thermo 
Fisher Scientific, Waltham, MA). Briefly, the LIVE/DEAD stain was prepared following 
the manufacturer product sheet to make a 2 μM calcein AM and 4 μM ethidium 
homodimer-1 (EthD-1) solution in PBS. Media was aspirated from the wells and samples 
were incubated in 250-300 μL of LIVE/DEAD stain (enough to cover the top of the 
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tissue) for 15 minutes at 37°C. After staining, tracheal samples were moved to wells 
containing 250 μL of PBS with the sprayed surface facing the bottom of the plate. 
Samples were imaged using the EVOS FL Auto 2 (Thermo Fisher Scientific) fluorescent 
microscope with GFP and RFP light cubes. Images were captured at 4x, 10x, or 20x 
across different areas of samples. 
 
2.7 Quantification of cell viability 
 
Cells were counted using a custom-made semi-automated ImageJ plugin. Briefly, 
raw images from each fluorescent channel (GFP and RFP) were counted separately 
using the plugin which ran a series of functions including background subtract. Particles 
were counted with minimum and maximum particle sizes based on the magnification of 
the image. Outlines of the particles counted were merged with the subtracted 
background image to visually verify that the plugin was appropriately counting cells. 
Additionally, manual counts were performed when feasible to validate the cell counts. 
 
2.8 Histology 
 
2.8.1 Freezing blocks 
 
At different time points, samples were frozen for histology and staining. Samples 
were placed upright (so that sections would be transverse) in small aluminum foil cups 
containing Tissue-Tek O.C.T. (optimal cutting temperature) compound (Sakura Finetek 
USA, Torrance, CA) and frozen using liquid nitrogen. Frozen tissue blocks were stored 
at -80°C until ready for sectioning. 
 
2.8.2 Sectioning 
 
Tissue blocks were placed in the Leica CM1900 cryostat (Leica Biosystems, 
Buffalo Grove, IL) 30 minutes prior to sectioning to allow the blocks to equilibrate to the 
proper cutting temperature. Porcine trachea blocks were sectioned at -13 to -16°C. 
Mouse lung blocks – used as positive controls for uteroglobin and surfactant protein C 
staining – were sectioned at -10 to -13°C. 10 μm sections were cut from blocks and 2 
sections were adhered to each slide. 10 sections were taken as a group in serial 
succession. After a group of sections, the cryostat was advanced approximately 1 mm 
further into the block and the next group of sections was taken. In total, approximately 
40-50 sections were taken from each block. One slide from each group of slides was 
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taken for H&E staining. The rest of the slides were either stored at -80°C or immediately 
used for immunofluorescent staining. 
 
2.9 Immunofluorescent staining 
 
Slides were removed from -80°C and allowed to come to room temperature for 
about 20 minutes. Optimal protocols were determined by using information from the 
product datasheet, paper references, and experimental trials. The protocols for each 
antibody are described below. Staining was carried out in a dark, humid chamber 
created by using a plastic box with wet paper towels on the bottom. Slides were elevated 
on a rack in the box. 
 
2.9.1 Cytokeratin 5 (CK5) 
 
Sections were fixed by covering them with 4% paraformaldehyde for 10 minutes 
at room temperature. Slides were rinsed with PBS. Sections were then permeabilized 
with 0.1% Triton X-100 for 5 minutes. Slides were rinsed with PBS. Sections were 
blocked with Normal Serum Block (Biolegend, San Diego, CA) for 1 hour at room 
temperature. Slides were rinsed with PBS. Sections were then incubated with rabbit 
monoclonal antibody to human CK5 conjugated with Alexa Fluor 488 (1:250 dilution, 
ab193894, Abcam, Cambridge, UK) at 4°C overnight. Control slides were incubated with 
PBS to prevent dehydration of sections (no primary antibody). Slides were rinsed with 
PBS. Coverslips were mounted using VECTASHIELD Hardset Antifade Mounting 
Medium with DAPI (H-1500, Vector Laboratories, Burlingame, CA) to counterstain cell 
nuclei. Slides were left out to dry for 15 minutes and then imaged using the EVOS FL 
Auto 2. 
 
2.9.2 Uteroglobin 
 
Sections were fixed by covering them with 4% paraformaldehyde for 10 minutes 
at room temperature. Slides were rinsed with PBS. Antigen retrieval was then performed 
by placing slides in citrate buffer (pH 6) heated to 90°C using a water bath for 10-20 
minutes. Slides were rinsed with PBS. Sections were blocked with Normal Serum Block 
(Biolegend, San Diego, CA) for 1 hour at room temperature. Slides were rinsed with 
PBS. Sections were then incubated with rabbit polyclonal antibody to human uteroglobin 
cross-reactive with mouse and rat (1:250 dilution, ab40873, Abcam, Cambridge, UK) at 
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4°C overnight. Control slides were incubated with PBS to prevent dehydration of 
sections (no primary antibody). After overnight incubation, slides were rinsed with PBS. 
All slides were then incubated with Cy3 AffiniPure Donkey Anti-Rabbit IgG secondary 
antibody (1:750 dilution, 711-165-152, Jackson ImmunoResearch Laboratories, West 
Grove, PA) for 1 hour at room temperature in the dark. Slides were rinsed with PBS. 
Coverslips were mounted using VECTASHIELD Hardset Antifade Mounting Medium with 
DAPI (H-1500, Vector Laboratories) to counterstain cell nuclei. Slides were left out to dry 
for 15 minutes and then imaged using the EVOS FL Auto 2. 
 
2.10 Mechanical testing 
 
Decellularized porcine trachea or native porcine trachea was cut into 
approximately 1 cm wide rings, unless otherwise stated (one experiment had 2 cm wide 
rings). Depending on the size of the trachea, anywhere from 5 to 13 samples were 
obtained from each trachea. The portion of the trachea with the first branching above the 
carina – found in pigs but not humans – was excluded from mechanical testing to 
maintain uniformity between samples. Mechanical testing was performed on a Mach-1 
tester (V500CSST, Biomomentum, Laval, Quebec, Canada). Samples were attached to 
the testing platform using Loctite 4013 Instant Adhesive (Henkel, Rocky Hill, CT) with the 
smooth muscle (trachealis) of the trachea on the surface of the platform. Tracheal rings 
were compressed using either a 12.5 mm diameter flat indenter (MA262, Biomomentum) 
or a 31.75 mm diameter flat indenter (MA263, Biomomentum). 
Before compression, a “Find contact” function was performed using the 
mechanical tester to find the surface of the tracheal ring with the indenter. This gave a 
height for the ring which was used to measure the force at 50% displacement of the 
samples. That measure was used to compare the compressive resistance between 
samples. Rings were compressed at a rate of 0.2 mm/s (roughly 1% of the sample 
height per second)47. Samples were compressed to 75% of the height determined using 
the “Find contact” function. Generally, this meant samples were fully occluded at the end 
of testing. Images of compressive mechanical testing are shown in Figure 2.3. 
 
2.11 Statistical analysis 
 
A one-way ANOVA using R/RStudio was performed on data sets with more than 
two groups for comparison. If the ANOVA determined there was a significant difference 
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between two different groups, post-hoc analysis was performed using a Tukey HSD test 
for all pairwise comparisons. When only two different groups were compared, a two-
tailed t-test using Excel was performed. P-values less than 0.05 were deemed to be 
significant. 
 
3. RESULTS 
 
3.1 Compressive resistance mechanical testing of native vs. decellularized 
porcine trachea 
 
After decellularization of porcine tracheas, the compressive resistance was 
compared to native tracheas using a mechanical tester to observe how the 
decellularization process would affect the mechanical properties. By measuring the 
compressive properties, the resistance to collapse of the trachea can be compared. 
Since tracheal collapse is a major concern after surgery, it is important to know that the 
decellularized scaffold can be as strong as the native trachea.  
The first mechanical test was performed as a sequence of stress relaxations 
(results not shown). Stiffness of the trachea was calculated and plotted as a function of 
the percent compression. Up to 30% compression, the stiffness of the native and 
decellularized tracheal rings was identical. From 40% to 70% compression, the native 
samples were slightly stiffer, but due to the variation in samples there appeared to be no 
difference between both groups. It was thought this setup would provide information 
about the aggregate modulus of the tracheal cartilage. However, due to the samples 
being rings, it was difficult to measure the area over which the load was being distributed 
to calculate an accurate stress. 
Following previous literature47,48, the compressive testing method was changed to 
the description in section 2.10. The next experiment was performed using the new 
method and resulted in a higher average compressive resistance for native samples 
than decellularized samples (Figure 3.1). A large standard deviation in the decellularized 
group meant that the result was not statistically significant after performing a two tailed t-
test assuming unequal variances (p=0.24). However there are only 3 samples in each 
group and all the samples were taken from one trachea so it is difficult to conclude 
anything. Samples were also around 2 cm in width which is larger than the small plate 
indenter used for testing. This could lead to edge effects that are not indicative of the 
trachea properties. 
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To limit edge effects, tracheal rings were cut to 1 cm in width for the next 
experiment. Samples were also ordered from proximal to distal and tested to note 
whether there are any differences in compressive resistance along the length of the 
trachea. There seems to be a trend of increasing compressive strength from proximal to 
distal for the native tracheal samples, but a decreasing compressive strength for the 
decellularized tracheal samples (Figure 3.2). The average force for the native group is 
also significantly higher than the decellularized group after testing with a two tailed t-test 
assuming unequal variances (p=4.7x10-6, Figure 3.3). An important caveat is that these 
samples were not kept hydrated in PBS during the sample processing and immediately 
prior to testing which may affect the results. 
To control for variability from edge effects with a small indenter, a large indenter 
was used in future experiments. The next experiment was performed with trachea 
obtained from APIC and samples were kept hydrated in PBS immediately prior to 
testing. Generally, the native trachea showed a higher compressive resistance 
compared to the decellularized trachea across the length of the trachea (Figure 3.4). 
However, there is a lot of variability present in both groups. Particularly, the first sample 
of the decellularized trachea was over 0.5 N stronger than the strongest native trachea 
sample. This meant after averaging across all samples and performing a two tailed t-test 
assuming unequal variances the data was not statistically significant (p=0.166, Figure 
3.5). Also, both groups show a decreasing trend from proximal to distal along the 
trachea which was not seen in the previous experiment. Sample hydration may explain 
these discrepancies. These differences may have to do with the different source of 
trachea and larger indenter as well. 
Experiments with tracheas from Hormel Foods using the large indenter show 
similar results. All tracheas display a slight decreasing trend in compressive resistance 
as expected since the trachea is much stiffer near the larynx (Figure 3.6). After pooling 
the native and decellularized trachea and performing a two tailed t-test assuming 
unequal variances the data was not statistically significant (p=0.199). Because the 
animals from Hormel Foods were larger than other sources, the compressive resistance 
of the tracheas was also higher. Therefore, it is not reasonable to compare the absolute 
forces across tracheas due to the different sizes of animals. Gender and strain of pig 
may also affect the compressive resistance of the trachea. 
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To control for these variables and more accurately measure the effect of the 
decellularization process, samples were paired in future experiments. With this new 
experimental design, decellularized samples generally followed the same trend as the 
native paired samples but at a lower strength. This can be seen in Figure 3.8 where the 
values are averaged and grouped by trachea. By calculating the mean difference in 
compressive resistance it seems that native trachea samples are significantly different 
from decellularized tracheal samples. Analyzing the data with a paired two sample t-test 
confirms this. All tracheas are statistically significant (trachea 1, p=0.043; trachea 2, 
p=0.0027; trachea 3, p=0.0037; trachea 4, p=0.00067). This suggests that the 
decellularization process does have an effect on the mechanical properties of the 
trachea. 
 
3.2 HBECs maintain high viability after spraying onto multiple types of 
substrates 
 
To show that HBECs could be applied to decellularized tracheal pieces via 
spraying, it first had to be shown that human bronchial epithelial cells could survive the 
spraying process. This was done by spraying cells into a well plate with or without 
culture media. Spraying into a well with culture media is a relatively soft surface for the 
cells to land on while spraying onto the empty well plate is a rigid surface for the cells to 
land on. Based on work previously done in the lab to characterize the sprayer, it was 
found that there were general values for the air pressure and liquid flow rates to obtain a 
proper spray. The range for the air pressure was between 10 and 30 psi and the liquid 
flow rate was around 0.2 mL/min. This produced droplet sizes with a mean diameter of 
30 μm and average velocities ranging from 8.5-13.5 m/s. Previous spraying experiments 
with these parameters showed greater than 90% viability. Subsequent experiments 
performed with newer sprayers at 1-2 mL/min and 30 psi were consistent with previous 
results. After 1 day, cells show good attachment after spraying into media at 2 mL/min 
(Figure 3.10) and there is no significant change in viability between the sprayed groups 
and the non-sprayed group (sprayer 1 to no-spray: p=0.743, sprayer 2 to no-spray: 
p=0.382). However, there was a significant difference in viability between the two 
sprayers tested (sprayer 2 to sprayer 1: p=0.0295). Although there is a statistical 
difference between the two sprayers, there is still a high viability, around 90%, for 
sprayer 2 (Figure 3.11). This suggests that the practical effect may not be significant. 
The variability seen between sprayers is likely due to the sprayers being custom-made. 
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What this confirms is the need for an automated, quality control process for building 
clinically applicable sprayers. Images in Figure 3.10 are representative of results 
obtained from two experiments testing two different sprayers. 
To reinforce the conclusion that HBECs have a high viability after spraying, 
another experiment was performed where viability was determined 1 hr after spraying 
rather than 1 day later to eliminate the potential confounding effects of cell proliferation. 
Since these data were gathered at 1 hour vs. 1 day, it may be more indicative of the 
direct effects of the sprayer on the cells. Data taken after 1 day may capture the 
proliferation of cells rather than the direct viability of cells after spraying. HBECs were 
sprayed at 1 mL/min onto decellularized trachea pieces, into wells with media, and into 
empty wells. All conditions show greater than 95% viability and there is no significant 
difference between the three groups (p=0.837, Figure 3.12). 
These data show that cells can survive the stresses of flowing through the 
sprayer, being aerosolized, and landing on different types of substrates. These 
preliminary experiments also show that cells can be cultured after spraying without 
contamination and sprayers can be used multiple times. 
 
3.3 Seeding of HBECs onto decellularized trachea pieces 
 
Prior to spraying, cells were seeded onto decellularized trachea pieces via 
pipetting to ensure that cells could be grown on the tissue. The first experiment was 
performed with HBECs only on decellularized trachea pieces and shows the importance 
of seeding density. After LIVE/DEAD staining, no cells can be found on any of the tissue 
samples (Figure 3.13b), but with such a high seeding density many cells are dead even 
in the cells-only control (2.4 million cells/well). Subsequent experiments were performed 
with additional cell types to observe differences in seeding and identify whether the 
cause of cell death was related to the cell type. 
In the next experiment, the seeding density was decreased to approximately 
500,000 cells/well. Again no living cells were seen on the tissue samples (Figure 3.13c). 
Fibroblasts were also added to the experimental conditions and showed similar results 
(images not shown). The control condition was similar across multiple seeding densities 
and cell types. The experiment was repeated with a seeding density of 100,000 
cells/well (Figure 3.13d) and showed similar results. 
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A549s were added to the experiments to see if there would be a difference in the 
seeding. A new trachea was also used for the seeding procedure. For this experiment 
images were taken at shorter timepoints (3 hrs and 24 hrs) to see when the cells were 
dying. Because tissues incubated with LIVE/DEAD stain cannot be cultured further, 
images at the 3 hr timepoint and 24 hr timepoint are from different tissue pieces. Again, 
cells look healthy in the cells-only control wells. At 3 hrs there are cells on the tissue in 
the A549 and HBEC conditions, however there are also many dead cells (Figure 3.14). 
At 24 hrs there are HBECs on the tissue but they still do not appear to be healthy 
compared to Figure 3.17. There are no viable fibroblasts on the tissues at either time 
point. 
To observe whether seeded cells were dying in the incubation well due to 
something in the tissue, or not attaching to the tissue and attaching to the bottom of the 
incubation well, live/dead images were taken of the incubation wells after removal of the 
tissue. Wells were also imaged after staining to see if many cells were being removed 
from the tissue during the staining process. Very few cells were seen (data not shown) 
and most were dead, consistent with the results on the tissue, but did indicate that cells 
were not coming off the tissue. 
To further explore whether cells being in contact with the tissue was leading to 
cell death, an experiment was performed where HBECs were either seeded onto 
decellularized trachea pieces or cocultured in a well with decellularized trachea without 
being directly on the tissue (Figure 3.15). At 1 hr there are many cells alive in both tissue 
and coculture conditions. Based on the rounded morphology of the cells, they still have 
not attached to the tissue or culture plate. At 2 hrs there are very few cells found on the 
tissue and those that are there are not viable. However, the coculture condition shows 
that cells are alive in the well and even surviving right next to the tissue. The morphology 
of the cells has also changed as the cells have had enough time to attach to the tissue 
or plate. Finally, at 18 hrs there are almost no viable cells on the tissue. Unlike earlier 
time points, the coculture condition also shows many dead or dying cells. These cells 
have also returned to a rounded morphology as they have detached from the plate. 
In an attempt to improve survival and attachment of cells to tissue, fetal bovine 
serum (FBS) and platelet lysate (PLTMax) were tested as supplements to media during 
the seeding process. Multiple experiments were performed with FBS/PLTMax using 
differing conditions. HBECs were seeded onto decellularized trachea with FBS and 
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PLTMax supplementing the culture media. Subsequently, HBECs were also seeded onto 
decellularized porcine lung pieces. In a final experiment, decellularized trachea pieces or 
decellularized porcine lung pieces were soaked in FBS or PLTMax prior to seeding with 
cells. These samples were then cultured with cell culture media after seeding. Other 
experiments with the addition of collagen or fibronectin to the surface of the 
decellularized tissue were also performed in an attempt to improve the attachment of 
cells. 
Addition of FBS or PLTMax as a supplement to the media did not improve 
seeding outcomes as there were very few viable cells (Figure 3.16). Soaking the tissues 
in FBS or PLTMax prior to cell seeding did not significantly improve results. Interestingly, 
cells cultured in the decellularized trachea-conditioned medium also did not survive 
indicating that something from the tissue was altering the media to make it inhospitable 
to the cells (Figure 3.16). The addition of collagen or fibronectin to the tissues did not 
make any difference as there were few, if any, viable cells (images not shown). 
After observing that cells were dying after seeding into wells without tissue but 
only the conditioned medium from decellularized trachea, it was hypothesized that 
something was being leached from the tissue. One idea was that residual detergent left 
from the decellularization process was not being thoroughly washed away and was 
being released into the media during soaking which led to cytotoxicity. To determine the 
detergent content of the tissues, a residual detergent assay was attempted as previously 
described49, but a cytotoxic presence of detergent could not be demonstrated. 
Throughout the previous experiments, it was observed that the color of the cell 
culture media would change rapidly (from pink to orange/yellow) indicating a drop in pH 
typically due to high metabolic activity of cells or bacterial contamination – but no 
contamination was evident. The pH was found to be around 6, which is below normal 
physiological pH of 7.2 – 7.4. To correct this, an assay with HEPES was performed to 
buffer the media from pH change. Different concentrations of HEPES were added to the 
media from 15 mM, 25 mM, 35 mM, and 45 mM to see if pH could be maintained and 
the cells would survive. Addition of HEPES at any concentration did not change 
outcomes of seeding and there were no viable cells on the tissues (images not shown). 
After many attempts using different cells and other types of decellularized 
tissues, samples were left to incubate longer and contamination did indeed appear. It 
was concluded that contamination of tissue may be the reason for cell death during the 
21 
 
experiments. Storing decellularized tissue in antibiotics (pen-strep) prior to cell seeding 
resulted in adherence of viable cells that could grow to confluency on the tracheal tissue 
(Figure 3.17). 
 
3.4 Successful application of HBECs onto decellularized tracheal pieces 
using sprayer device 
 
After solving the issue of cells dying and optimizing the seeding protocol, human 
bronchial epithelial cells were sprayed onto decellularized trachea pieces (Spray – 
trachea). HBECs sprayed into media (Spray – media), pipetted onto trachea (Pipette – 
trachea), and pipetted into media (Pipette – media) were used as controls. Multiple 
experiments were performed with representative LIVE/DEAD staining images shown in 
Figures 3.18 and 3.19. Coverage of cells in the first experiment (images not shown) 
appeared to be sparse at the early time points (24 hrs and 48 hrs). This improved with 
time, however, as there was better coverage at day 3 which may be due to proliferation 
of cells. Viability in the first experiment is above 80% for 24 hrs and 72 hrs but around 
75% for 48 hrs (Figure 3.20). The high variability for the day 2 sample indicates that 
there are certain areas of the tissue with low cell viability and other areas with high cell 
viability. These viabilities are lower than the cells-only control and the pipette-seeded 
trachea control at 72 hrs Statistical analysis was performed after grouping samples by 
day. The only test that was statistically significant was on day 3 between the sprayed 
trachea and the pipette-seeded trachea (p=0.0144, Figure 3.20). 
The second experiment shows much better coverage of cells at 24 hrs and 72 
hrs (Figure 3.18). Also, viabilities at these time points are above 80% (Figure 3.21). The 
sprayed trachea sample at day 1 is statistically different from the spray media sample 
(p=0.0152). At day 8, the viability drops to around 40% which is significantly lower than 
all other groups at the same time point (Spray trachea-Spray control media, p=0.0014; 
Spray trachea-Pipette control trachea, p=7.81x10-5; Spray trachea-Pipette control media, 
p=3.52x10-4). It is possible this is due to some variability caused by the spraying 
procedure or culturing of tissues and not necessarily because of the sprayer itself. For 
example, tissue pieces sprayed near the end of the spraying process may not receive 
the same number of cells as those at the beginning or middle. Throughout the spraying, 
cells may settle inside the syringe leading to a lower concentration that is sprayed. In 
this experiment, the sprayer began to produce an abnormal, erratic spray pattern with 
some of the spray landing outside of the intended wells. This could easily explain why 
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the sprayed tissues at day 8 have many fewer cells compared to the tissues with 
pipetted cells. 
In the final experiment (Figure 3.19), there is moderate coverage at the early 
timepoint (72 hrs) compared to the later timepoint (day 6). Although in both cases, the 
viability is above 80% (Figure 3.22). At day 6 there is very good coverage of the tissue, 
most likely due to proliferation of cells, with small areas throughout the tissue still lacking 
cells. 
 
3.5 Sprayed HBECs on trachea pieces express lung epithelial cell markers 
 
Three spray experiments were performed with tissue pieces cultured up to 9 
days. Samples from these experiments were frozen and sectioned. Some samples were 
stained with hematoxylin and eosin (H&E) to observe cells on the surface of the sprayed 
tissues. Representative images of H&E staining are shown in Figure 3.23. Cells show 
good coverage across the tissue as there is a continuous layer of cells (solid arrows) on 
the epithelial membrane. Some samples also show what appears to be 
pseudostratification as some cells are in different layers. When compared to a native 
human trachea (images not shown), epithelial cells in the native trachea have a much 
more polarized architecture with cells appearing elongated, containing cilia, and facing 
directly outward from the epithelial surface (apical-basal polarity). However, cells in the 
sprayed sample are simply layered on top of one another and do not show signs of cilia. 
Other samples were immunofluorescently stained for pulmonary epithelial cell 
markers CK5 and uteroglobin. HBECs express the basal cell marker, CK5, even 8 days 
after being sprayed onto decellularized trachea pieces (Figure 3.24). The staining 
appears almost identical to the positive control samples (native porcine trachea). HBECs 
also express the club cell marker, uteroglobin, 8 days after being sprayed onto 
decellularized trachea pieces (Figure 3.25). Sprayed samples show some diffuse 
staining in the cartilage closer to the epithelial layer. This staining is not seen in the 
negative control (sprayed samples with secondary antibody only). Positive control 
samples (adult mouse lung) show a similar diffuse staining as seen by the hazy 
fluorescent signal surrounding the bronchioles where uteroglobin is expected. This type 
of staining is likely due to uteroglobin being a secreted protein. 
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3.6 Spraying onto intact trachea using a vertical mini-bioreactor 
 
After having success spraying onto decellularized trachea pieces in a well plate, 
spraying was attempted on complete tracheal segments in an upright position. The goal 
of this was to show that spraying could be carried out in a clinically relevant setting 
where the trachea is intact and the orientation of the tissue may not be conducive to cell 
adhesion. In all previous spraying experiments, tracheal tissue pieces were in a well 
plate with the sprayed surface facing up. This meant that gravity aided in the seeding 
process. Clinical applications would not necessarily allow for this as there may be 
different orientations and topographies to spray onto. 
Unfortunately there was not any success in delivering cells onto the scaffold this 
way. Because of gravity, the cell suspension that was sprayed onto the tissue would 
pool at the bottom of the mini-bioreactor. Even after spraying lower volumes (50-100 μL) 
with higher cell concentrations, outcomes were similar and there were no cells attached 
to the scaffold. This could be due to the high cell concentrations, which may have led to 
clumping of cells, or the liquid volume is still too high. An experiment to improve cell 
adhesion was performed by spraying fibronectin onto the surface of the scaffold prior to 
spraying HBECs. This did not lead to improved outcomes for cell attachment. 
 
4. DISCUSSION 
 
4.1 Compressive mechanical testing of decellularized porcine trachea is 
inconclusive 
 
As mentioned in Section 1.1, the mechanical properties of the trachea are 
important because of its function in maintaining a patent airway. Therefore, measuring 
the compressive resistance of decellularized porcine trachea is necessary when creating 
engineered tracheal grafts. It is important to keep in mind that these results are based on 
in vitro testing of tracheal rings. Removal of the trachea from the native state will 
significantly alter the mechanics since connective tissue supports and anchors the 
trachea. However, this can provide some information on the effects of the 
decellularization process on the scaffold and important factors for future studies on 
trachea mechanics. 
After reading previous literature on mechanical testing of trachea47,48, it was 
decided that the method of multiple stress relaxation steps was not the best way to 
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measure the physiologically relevant mechanical properties of the trachea. Although this 
method can provide data about the viscoelasticity of the trachea, it does not accurately 
describe the compressive resistance of the trachea since the sample is allowed to relax 
at each step of the compression. Subsequent experiments adopted the method of a 
constant compression of the trachea until lumen occlusion and using the force required 
for 50% compression as an indicator for the compressive resistance. 
It was found that there are multiple factors that affect the mechanical testing 
results including sample dimensions/size of the indenter, water content in the tissue, and 
location along the trachea. 
Butler et al. find no significant difference between mechanical properties of 
decellularized human trachea after vacuum decellularization50. They performed a larger 
range of tests – including tensile tests and compression under different orientations – 
than is presented here, and they find no significant difference compared to native human 
trachea. Some of the results found in this thesis would also suggest that there is no 
difference between decellularized porcine trachea and native porcine trachea. However, 
one thing that Butler et al. note is that the lack of significance may be due to the high 
variance between samples. Results shown here are in agreement with this. 
In one experiment, rings were around 2 cm in width and the indenter used was 
only 1.25 cm in diameter. This led to edge effects since the compression plate was too 
small to evenly distribute the load across the trachea. Some rings were compressed 
unevenly, which produced inaccurate force measures. 
To limit edge effects, tracheal rings were cut to 1 cm in width for the next 
experiment. However, the samples were not kept hydrated in PBS during the sample 
processing and immediately prior to testing. As a result there may be drying effects that 
change the mechanical properties since water plays an integral role in the compressive 
resistance observed in the trachea. Regardless, it is interesting to see that there is an 
opposing trend for the native vs. decellularized group. It is unclear why this happened, 
but one hypothesis is that this is a sign of varying protein content based on location in 
the trachea. Alternatively, the decellularization process may have a varied effect along 
the length of the trachea. 
All previous experiments used different tracheas or different samples within the 
same trachea for each experimental condition (native vs. decellularized). It was 
determined that this method is most likely capturing much of the variability between 
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tracheas rather than the effect of the decellularization process. To account for this, the 
next experiment involved pairing samples where tracheal rings were tested before and 
after decellularization and then compared. This should more accurately measure the 
effect of the decellularization process on the compressive resistance of the tracheal 
pieces. 
The results indicated that the decellularization process does have an effect on 
the mechanical properties of the trachea. However, it is unclear whether this has a 
practical effect on the engineered construct. For example, will this change in 
compressive resistance hinder the ability of epithelial progenitor cells to differentiate into 
all the cell types of the respiratory epithelium (ciliated cells, goblet cells, etc.)? The 
results showing the variability of samples within an individual trachea would suggest that 
the decrease caused by decellularization may not produce a noticeable effect on the 
final construct. Essentially, the effect caused by decellularization is smaller than the 
variability already present within the trachea. Indeed, when performing a two-tailed t-test 
assuming unequal variances for each trachea, trachea 1 (p=0.180) and trachea 2 
(p=0.080) are not statistically significant anymore while trachea 3 (p=0.0234) and 
trachea 4 (p=0.0055) still are. This indicates that further testing is required to make a 
conclusion. 
 
4.2 Sprayer can be used for cell deposition onto multiple substrates 
without adversely affecting cell viability 
 
Results of preliminary spraying experiments demonstrate that cells can be 
sprayed without harmful effects on cell viability. There is generally high viability soon 
after spraying (1 hr to 1 day) with values ranging from 90-98%. These values are much 
higher than those previously reported. Hendriks et al. looked at optimizing cell viability 
using a cell spray device (Duploject) that is almost identical – in terms of the 
aerosolization method – to the one used in this research51. They found a viability around 
60% using the following parameters: pressure (P) = 0.4x105 Pa, nozzle-substrate 
distance (h) = 3 cm, liquid viscosity (μ) = 1 mPa∙s, and a glass substrate. For 
comparison, typical parameters used in this research were approximately P = 2x105 Pa, 
h = 2 cm, and μ = 1 mPa∙s, and multiple types of substrates. These conditions are 
theoretically much harsher to the cells due to the higher pressure and closer distance of 
spraying. This translates to smaller droplet sizes and higher impact velocities which are 
both predicted to have lower viabilities. Additionally, Hendriks et al. posit that poor 
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outcomes may be unavoidable due to clinical constraints such as the nozzle-substrate 
distance which may be around 1 cm51. The stiffness of the substrate may also be 
problematic as they found that spraying onto a gelatin surface similar in stiffness to 
muscle tissue resulted in viabilities close to that of a glass substrate. 
Based on the findings in this thesis though, the sprayer device used for this 
research may be able to overcome these challenges since high viability is maintained at 
higher pressures, closer distances, and stiffer substrates. This is likely due to an 
improvement in sprayer nozzle design which can better control droplet size and spray 
velocity37,51. The aerosolization method may also be a factor in the improved cell 
viability. To produce an aerosol, this device has air traveling through the inner lumen 
interacting with liquid in the outer lumen. Some devices that have been studied use an 
opposite configuration with liquid in the inner lumen and air surrounding the liquid37,52. 
Others have also used commercial airbrushes53 and air-free devices (Penn Century 
Microsprayer)54 to aerosolize cells. Ultimately, these factors affect the pressure, shear, 
and elongational forces that are experienced by cells during spraying and can lead to 
cell death40. 
 
4.3 Troubleshooting of HBEC seeding onto trachea 
 
Many experiments were performed to troubleshoot why seeded cells were dying 
on the decellularized trachea. Ultimately, contamination was found to be the culprit. Still 
it is useful to discuss the rationale behind the experiments performed to distill some 
useful information for future research and identify potential pitfalls. There are essentially 
5 important parameters to consider when seeding cells onto decellularized tissue: 1) 
seeding density, 2) media factors for optimal cell survival and differentiation, 3) materials 
for improved delivery and attachment of cells, 4) residual detergent, and 5) preventing 
tissue contamination. 
Initial seeding experiments had densities of 2.4x106, 5x105, and 1x105 cells/well 
seeded into tissues on 24-well plates. After cells died, these densities were too high to 
reasonably expect cells to survive on the tissue based on the size of the tissue (approx. 
1 cm2) and the amount of media available to the cells (approx. 1 mL). Conconi et al. 
describe using a seeding density of 500,000 cells/cm2 on decellularized tracheal 
matrices55. If contamination had not been an issue, the second and third experiments 
may have been optimal in terms of seeding density. Indeed, future experiments of 
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seeding and spraying were seeded at a range of 100,000 to 500,000 cells/cm2. Maughan 
et al. have reported that 1x106 cells/cm2 or greater may be needed for cell seeding in 
tracheal tissue engineering56. Based on these data it would be advisable to run an assay 
early on with different seeding densities using the cells and tissue that are to be seeded 
to determine the optimal conditions. Maughan et al. also discuss the potential for 
reconsidering seeding as a suspension and moving towards cell sheets as a way to 
improve cell coverage56. An alternative to cell sheets is the spray-based delivery system 
of cells investigated here. 
Another idea was to add serum to the media to improve cell viability57. The 
airway epithelial cell media used for seeding experiments is serum-free, which means it 
does not contain any serum proteins. Serum, commonly in the form of FBS, is added to 
media during cell culture to provide different growth factors that improve the survival and 
proliferation of cells. Therefore, adding FBS to the media or incubating the tissue in FBS 
prior to seeding could improve the outcomes. An alternative to FBS is human platelet 
lysate which also contains growth factors and proteins for cell culture. It is generally 
used for culture of MSCs to increase the growth rate and maintain genetic stability of 
cells. PLTMax, a human platelet lysate, was also used to see if it would provide any 
improved results. It was interesting to see that incubating the tissues in these reagents 
led to some slightly improved outcomes, but no significant improvement. This was likely 
due to short-term effects that improved the environment for HBECs compared to the 
contaminating organisms. 
Cells bind to the ECM through integrins with different integrins binding to different 
ECM proteins (e.g. α5β1 integrin binds to fibronectin through the RGD sequence)
58,59. 
Common ligands for integrins included collagen, fibronectin, and laminin58,59. Therefore, 
coating scaffolds with collagen or fibronectin was thought to improve the attachments of 
cells to the construct and therefore the survival. This is important to consider when 
seeding since cell adhesion is critical to seeding outcomes. Use of biomaterials such as 
fibrin, collagen, and fibronectin has been shown to improve outcomes35,60–62. However, 
this step should only be optimized after it is shown that cells can survive with the tissue 
being seeded. This approach will be discussed further as a route to clinical application in 
Section 4.4. 
Finally, measuring the residual detergent content in a decellularized tissue can 
be a relatively simple way to see if detergents are adversely affecting the seeding 
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process. It was shown by others that a relatively low concentration of detergents is 
necessary to kill sensitive cells such as HBECs49. This emphasizes the importance of 
properly rinsing decellularized tissue and optimizing a decellularization protocol that 
works for the tissue of interest. 
 
4.4 Sprayer can be used to deliver bronchial epithelial cells onto 
decellularized trachea 
 
Multiple experiments showed that HBECs can be successfully delivered onto 
decellularized trachea scaffolds using a spraying device and cultured up to 9 days. After 
one day there is approximately 90% viability of HBECs on tracheal samples. At day 3, 
viability drops to around 80%. Subsequently, though, HBECs appear to grow to 
confluence at 6 days. This shows that cells are able to proliferate in culture on 
decellularized tracheal scaffolds after initial cell death caused by spraying. 
Many samples have dead cells scattered throughout the surface of the tissue. 
This is likely due to variability caused by the spraying procedure or culturing of tissues. 
For example, tissue pieces sprayed near the end of the spraying process may not 
receive the same number of cells as those at the beginning or middle. Throughout the 
spraying process, cells may settle inside the syringe leading to a lower concentration 
that is sprayed. Settling of cells could eventually lead to cell clumping and cell death 
which would explain that areas of dead cells found on tissues as well. In experiment #2 
(Figure 3.21), the sprayer began to produce an abnormal, erratic spray pattern with 
some of the spray landing outside of the intended wells. This could easily explain why 
the sprayed tissues at day 8 have many fewer cells compared to the tissues with 
pipetted cells. 
When interpreting the data, a major limitation is that different samples were used 
for imaging and measurements at different time points. This was done because 
incubation of cells with LIVE/DEAD stain causes cell death over time. So viability data 
could not be obtained from the same sample over time. Consequently, variability in the 
cell spraying procedure from different samples and experiments could cause differences 
in viability between samples. 
It is interesting to note that cells seeded via pipetting or spraying appear to be 
aligning preferentially along one axis (Figures 3.17 and 3.18). Bronchial epithelial cells 
do exhibit planar polarity along the longitudinal axis of the trachea which is necessary for 
proper orientation of the cilia in the mucociliary escalator. This creates a directional 
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beating of cilia and forces mucus up and out of the airways. If the cells were not 
polarized in this way, cilia would beat in random directions and potentially produce 
forces in opposing directions leading to no movement of mucus out of the airways. Since 
the alignment axis is unknown, it is difficult to assert whether the decellularized matrix, 
particularly the tunica mucosa and submucosa, are providing topographical cues (i.e. 
aligned microgrooves on the surface) that produce the observed alignment of the cells. 
Melo et al. have used this membrane layer as a biotranswell and observed that it leads 
to a polarized architecture13. Although they focused on the apicobasal polarization, it is 
likely this layer participates in planar polarization as well. This finding warrants further 
research. If it can be shown that the tunica mucosa and submucosa promote planar 
polarity it could be a benefit to airway engineering and understanding the polarization of 
cells. 
H&E staining of sprayed samples shows some blue staining in the lacunae of the 
cartilage which indicates the presence of cellular material. This is somewhat surprising 
since the trachea has been decellularized prior to spraying so ideally there should not be 
any cellular content in the scaffold. However, this is consistent with other research 
showing that some cellular debris is retained inside the cartilage19,50,55. It has been 
described that the tracheal cartilage displays low antigenicity because of the limited 
blood supply and the dense ECM protecting the chondrocytes15, so the presence of 
some cellular material after the decellularization process may be acceptable11,25. 
Additionally, the epithelium is the main site of rejection, thus regenerating an intact 
epithelium could protect grafts from rejection and reduce immunosuppression15. Using 
multiple decellularization cycles can reduce the amount of DNA content left in the 
scaffolds; however, the harsh decellularization adversely affects the mechanical 
properties of the tissue 27. Therefore, a proper balance has to be maintained to remove 
enough cellular material to eliminate the possibility of rejection while still preserving the 
mechanical strength of the tracheal scaffold. 
 
4.5 Considerations for spraying cells in a clinically relevant setting 
 
To show that the cell sprayer could be used in various clinical applications where 
the tissue topography is not favorable for cell adhesion, cells were sprayed into tracheal 
ring segments in an upright position. Multiple experiments were performed but it was 
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difficult to get cells to attach to the scaffolds when spraying in an upright position. These 
experiments identify considerations and improvements for the spraying process. 
One experiment was performed with fibronectin sprayed onto the scaffold as a 
coating hypothesizing that this would improve cell adhesion. However, this did not 
improve cell engraftment. The concentration of fibronectin may have to be optimized for 
there to be a substantial effect on cell adhesion. Use of fibronectin should be studied 
further since it promotes HBEC adhesion and survival 63. Other biomaterials such as 
collagen and laminin are also good candidates for cell delivery. Collagen has been used 
in a non-spray setting as a matrix to deliver airway cells onto a decellularized tracheal 
matrix60. Laminin is promising since it is the first ECM component that cells encounter 
when seeded onto a decellularized trachea matrix13. Ultimately, the solution may be to 
use another biomaterial such as fibrin in combination with the cell suspension to spray 
onto the scaffold. Others have shown that fibrin can be used with a cell spraying device 
to keep cells stationary immediately after spraying because of its rapid 
polymerization31,35–37,40,41. It is also favorable for regenerative applications since it 
degrades relatively quickly, so cells can proliferate and differentiate after degradation. 
Additionally, the cell carrier may provide differentiation cues if stem cells are being used 
in regeneration64. 
Another concern is the ability for the cell sprayer to deliver high concentration cell 
suspensions. Throughout multiple spraying experiments the sprayer would become 
clogged due to clumping of cells. This is a critical shortcoming since large amounts of 
cells are required to regenerate solid organs such as the lung. Clumping of cells can not 
only obstruct the sprayer but block smaller airways during recellularization. The current 
design could affect the ability to spray viscous biomaterials as well. To overcome these 
challenges, lower cellular concentrations may be used, scaffolds can be sprayed with 
multiple passes, or the sprayer design would have to be altered. 
For clinical translation, the sprayer will likely have to be developed as a single-
use device. Currently, the device is manufactured as a custom, handmade product. To 
move to clinical application, the device will require an automated manufacturing process 
not only to scale up but to reduce device variability. This would allow for better quality 
control and standardized device specifications. As mentioned above, small changes in 
the nozzle design and dimensions can lead to extremely different droplet sizes, 
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velocities, and forces experienced by cells. Therefore, maintaining uniformity across 
devices will be key to successful outcomes. 
 
4.6 HBECs maintain at least two epithelial cell markers after spraying 
 
A crucial component of using HBECs for tracheal tissue engineering or airway 
wound healing is the multipotent capacity of these cells. This means that they can 
differentiate into ciliated cells and goblet cells of the upper airway. As mentioned in 
Section 1.1, removal of pathogens from the airway is one of the main functions of the 
trachea. Thus, having properly functioning ciliated cells and goblet cells is important for 
an engineered tissue or for repairing an airway injury. To show that HBECs maintain this 
capacity after spraying and culture, IF staining was performed on sprayed trachea 
samples. IF staining shows that after culturing sprayed trachea samples for 8 days, 
HBECs still express CK5 and uteroglobin, which are markers for basal cells and club 
cells, respectively. This is in agreement with research that shows HBECs express 
markers of different lung cell types suggesting the potential for differentiation into those 
cell types65. Delgado et al. show that HBECs can display markers of distal lung cells65. 
Unfortunately, the research presented here is unable to definitively show that 
sprayed HBECs display ciliated cell and goblet cell markers that are most important for 
the trachea epithelium. Basal cells are thought to be able to differentiate into ciliated 
cells and goblet cells when necessary, so it is promising that the CK5 marker was found. 
Additionally, club cells are typically found in more distal parts of the lung such as 
bronchioles which agrees with Delgado et al. in suggesting that HBECs have larger 
differentiation capacity than previously thought. From these staining results, it may be 
reasonable to conclude that the forces experienced by the cells through spraying and 
the subsequent biological effect do not adversely affect the expression of lung markers. 
It is yet to be shown that this can translate directly to differentiation capacity. 
It is important to remember that these results do not conclusively show that the 
HBECs are expressing these markers due to being cultured on the decellularized matrix. 
It is quite possible that these markers are already being expressed during culture in 
polystyrene flasks and they are just maintained after spraying. One way to determine 
what is happening would be to perform staining of cells cultured in a chamber slide. 
Without this information, it is inconclusive one way or the other. Still, this result is 
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important because it shows at the very least that spraying of HBECs onto decellularized 
porcine trachea does not negatively affect their epithelial cell marker expression. 
 
5. CONCLUSION 
 
The research presented here focuses on a method for delivering cells to airways 
using a cell spraying device. To demonstrate the feasibility of the process, HBECs were 
sprayed onto decellularized porcine trachea. Compressive testing of decellularized 
porcine trachea was inconclusive, but suggests that some compressive resistance is lost 
after decellularization. After spraying onto different substrates, HBECs displayed high 
viability. Sprayed tissues were cultured over one week and the cells retained key 
epithelial cell markers. This represented the potential for differentiation; however, cells 
were not definitively differentiated. Cells could not be sprayed in a clinically relevant 
scaffold setting due to lack of cell attachment. 
Overall, results suggest that creation of a tracheal graft or re-epithelialization of 
airways is achievable, but progress still needs to be made in maintaining differentiating 
epithelial cells and improving cell attachment. An air-liquid interface culture is likely 
necessary for differentiation, and cell attachment could be improved by spraying cells 
within a hydrogel. The success of this method could eventually be translated to whole 
lung engineering and application of cells to other tissue engineered constructs. 
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Figure 2.1 – Images of sprayer setup.  
Picture of syringe pump with water-filled syringe and tubing connected to sprayer (left). 
Picture of the sprayer connected to the air compressor tube and the syringe containing 
cell suspension (right). 
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Figure 2.2 – Image of mini-bioreactor setup.  
Picture of mini-bioreactor with decellularized trachea (indicated by the solid arrow). 
Bottom of the bioreactor is filled with 2% agarose to keep the trachea secure. 
 
 
 
 
 
Figure 2.3 – Images of compressive mechanical testing. 
Pictures of mechanical testing of native porcine trachea at 3 different stages: (a) no 
compression, (b) 50% compression, and (c) fully compressed.
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Figure 3.1 – Trachea ring compression with small indenter and 2 cm rings.  
n=3 for both groups. Testing was performed on one trachea cut into multiple rings 
(approx. 2 cm in width). Average forces at 50% compression are reported for each group 
with error bars showing the standard deviation. 
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Figure 3.2 – Trachea ring compression by location (proximal to distal) with small 
indenter and 1 cm rings. 
One trachea for each group cut into 7 different rings (approx. 1 cm in width). Samples 
ordered and tested from proximal (1) to distal (7). Forces at 50% compression are 
reported for each sample. 
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Figure 3.3 – Data from Figure 3.2 averaged by treatment group (native vs. 
decellularized).  
n=7 for both groups. Average forces at 50% compression are reported with error bars 
showing the standard deviation. Three asterisks indicate statistical significance at the α 
= 0.001 level (p=4.7x10-6). Samples were not paired since a different trachea was tested 
for each group. 
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Figure 3.4 – Trachea ring compression by location (proximal to distal) with large 
indenter and APIC trachea. 
One trachea for each group cut into 11 different rings (approx. 1 cm in width). Samples 
were ordered and tested from proximal (1) to distal (11). Forces at 50% compression are 
reported for each sample. 
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Figure 3.5 – Data from Figure 3.4 averaged by treatment group (native vs. 
decellularized).  
n=11 for both groups. Average forces at 50% compression are reported with error bars 
showing the standard deviation. There is no statistical significance between the groups 
and samples were not paired. 
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Figure 3.6 – Trachea ring compression by location (proximal to distal) with large 
indenter and Hormel tracheas. 
Two tracheas for each group cut into 13 different samples (approx. 1 cm in width). 
Samples ordered and tested from proximal (1) to distal (13) or vice versa. Forces at 50% 
compression are reported for each sample. The variability seen in “Decellularized 
trachea 1” at location 4 and 5 is likely due to uneven compression where the samples 
were slanted leading to a higher force than expected. 
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Figure 3.7 – Data from Figure 3.6 averaged by treatment group (native vs. 
decellularized).  
n=26 for both groups. Average forces at 50% compression are reported with error bars 
showing the standard deviation. There is no significant difference between both groups 
and samples were not paired. 
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Figure 3.8 – Data from paired samples experiment averaged by treatment group 
for each trachea. 
n=6 for trachea 1 and 3, n=5 for trachea 2, and n=7 for trachea 4. Average forces at 
50% compression are reported with error bars showing the standard deviation. Asterisks 
indicate statistical significance after a paired-sample t-test (* p<0.05, ** p<0.01, *** 
p<0.001). Triangles indicate statistical significance after a two-tailed t-test assuming 
unequal variances (Δ p<0.05, ΔΔ p<0.01). 
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Figure 3.9 – Mean difference in compressive resistance after decellularization.  
The differences between the forces at 50% compression were calculated for each 
sample before and after decellularization (difference = native - decell). These differences 
were then averaged for each trachea and reported here with error bars showing the 
standard deviations. Positive value indicates that the native samples had a higher force 
than the decellularized samples. 
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Figure 3.10 – Representative LIVE/DEAD staining images of spraying HBECs into 
media.  
Cells were sprayed at 30 psi and 2 mL/min flow rate. Total volume of 250 uL sprayed 
and cell concentration of 1 million cells/ml for an approximate seeding density of 250,000 
cells/well. HBECs show excellent viability after spraying into media. (a-b) Control 
condition with cells seeded into an empty well of a 24-well plate via pipetting. (c-d) 
Representative images of cells sprayed into wells with media. All images are taken 1 day 
after spraying at 10x magnification. 
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Figure 3.11 – Cell viability one day after spraying into media.  
n=3 for the no spray group and n=8 for sprayers 1 and 2. There was an outlier for 
sprayer 2 around 76% which led to the large deviation. Averages for each group are 
reported with error bars showing the standard deviation across all the samples in that 
group. One asterisk indicates statistical significance between Sprayer 2 and Sprayer 1 at 
the α = 0.05 level (p=0.0295).  Cells were sprayed at 30 psi and 2 mL/min flow rate. 
Total volume of 250 uL sprayed and cell concentration of 1 million cells/ml for an 
approximate seeding density of 250,000 cells/well. 
93.77 96.19 89.31 
80
82
84
86
88
90
92
94
96
98
100
V
ia
b
ili
ty
 (
%
) 
HBEC viability one day after spraying into media 
No-spray control (pipette) Sprayer 1 Sprayer 2
* 
46 
 
 
 
Figure 3.12 – HBEC viability one hour after spraying onto trachea, media, and 
empty well.  
n=3 for each group. Average viability for each group is reported with error bars showing 
the standard deviation across the samples in that group. 
 
 
 
 
 
 
 
Figure 3.13 – Representative  LIVE/DEAD staining images of HBECs pipette-
seeded on decellularized trachea pieces at different seeding densities.  
(a) Control condition with cells seeded at 100,000 cells/well into an empty well of a 24-
well plate. Images of HBECs seeded at different densities – (b)  2.4 x 106 cells/well, (c) 
500,000 cells/well, and (d) 100,000 cells/well – show no cells on the surface of the 
tissue. All images are taken 1 day after seeding at 10x magnification. 
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Figure 3.14 – LIVE/DEAD staining images of HBECs, FBs, and A549s pipette-
seeded onto decellularized trachea pieces.  
(a-c) Control conditions with (a) A549s, (b) FBs, or (c) HBECs seeded into empty wells 
of a 24-well plate (50,000 cells/well). Tissue samples after 3 hrs seeded with (d) A549s, 
(e) FBs, or (f) HBECs. Tissue samples after 24 hrs seeded with (g) A549s, (h) FBs, or (i) 
HBECs. Tissue pieces were soaked overnight in respective culture media prior to 
seeding with cells. Images are taken 3 hrs and 24 hrs after seeding at 10x magnification. 
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Figure 3.15 – Decellularized trachea seeding and co-culture assay over one day.  
HBECs were seeded onto decellularized trachea or into a well containing tissue to see 
whether cell death is due to contact with the tissue or something released by the tissue. 
Images of HBECs at 1 hr seeded onto trachea (a) or cocultured with trachea (b) and at 
18 hrs seeded onto trachea (c) or (d) cocultured with trachea. Image of HBECs for cells-
only control (e). Images taken at 10x magnification except for (b) which was taken at 4x 
magnification. 
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Figure 3.16 – Representative LIVE/DEAD staining images of supplementing media 
with FBS or PLTMax after seeding and culturing cells in tissue-conditioned media.  
(a-c) HBECs seeded onto decellularized trachea pieces and cultured with (a) 2% FBS in 
culture media, (b) 2% PLTMax in culture media, or (c) only culture media. (d-f) Control 
conditions with HBECs seeded into empty wells of a 24-well plate and cultured with (d) 
2% FBS in culture media, (e) 2% PLTMax in culture media, or (f) only culture media. (g-i) 
HBECs cultured in (g) decell. trachea conditioned media, (h) decell. porcine lung 
conditioned media, (i) normal cell culture media. All images are taken after 1 day at 10x 
magnification. 
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Figure 3.17 – Storing decellularized trachea in pen-strep prior to HBEC seeding via pipetting.  
Stored decellularized trachea in pen-strep and incubated tissue pieces in media overnight before seeding via pipetting. Images of 
HBECs in the incubation well and seeding well at (a-b) 24 hrs, (c-d) 48 hrs, and (e-f) 72 hrs Images of HBECs on decellularized 
trachea at (g-i) 24 hrs, (j-l) 48 hrs, and (m-o) 72 hrs All images taken at 4x or 10x magnification.
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Figure 3.18 – Spraying HBECs onto decellularized trachea pieces (8 day).  
Tissue was stored in pen-strep after decelling and incubated in media overnight before 
seeding (250,000 cells/cm2). Images of HBECs 24 hrs (a-b), 72 hrs (c-d), and 8 days (e-
f) after being sprayed onto decellularized trachea pieces in a 24-well plate. Images of 
HBECs 8 days after being pipetted onto decellularized trachea pieces (g-h) as a control. 
Images of HBECs 8 days after being sprayed into media (i) or pipetted into media (j) as 
controls. Images taken at 4x and 10x magnification. 
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Figure 3.19 – Spraying HBECs onto decellularized trachea pieces (6 day).  
Tissue was stored in pen-strep after decelling and incubated in media overnight before 
seeding (80,000 cells/cm2). Images of HBECs 72 hrs (a-d) and 6 days (e-h) after being 
sprayed onto decellularized trachea pieces in a 24-well plate. Images taken at 72 hrs 
and day 6 at 4x and 10x magnification.  
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Figure 3.20 – HBEC viability for spray experiment #1 (3 day).  
Each bar represents a single sample with n technical replicates (images). Average viability of all the images taken from that sample 
is reported and error bars show the standard deviation of the viabilities within that sample. Asterisk indicates statistical significance 
between day 3 samples (p=0.0144). 
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Figure 3.21 – HBEC viability for spray experiment #2 (8 day).  
Each bar represents a single sample with n technical replicates (images). Average viability of all the images taken from that sample 
is reported and error bars show the standard deviation of the viabilities within that sample. One asterisk indicates statistical 
significance at α = 0.05 level between day 1 samples. Three asterisks indicate statistical significance at the α = 0.001 level between 
day 8 samples. 
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Figure 3.22 – HBEC viability for spray experiment #3 (6 day).  
n=3 for each group. Average viability for each group is reported with error bars showing 
the standard deviation across the samples in that group. Three asterisks indicate 
statistical significance at the α = 0.001 level between day 8 samples. The increased 
viability seen at Day 6 suggests that cells can proliferate after spraying to cover the 
surface of the tissue. 
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Figure 3.23 – Representative H&E staining images of sprayed trachea samples at 
day 9.  
Images at 10x (a-b) and 20x (c-d). Solid arrows indicate HBECs, dashed arrows indicate 
the epithelial membrane, and cartilage is labeled with text. Images (a-b) are from a 
different experiment than images (c-d). H&E shows good coverage of epithelial layer at 
day 9. 
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Figure 3.24 – Representative CK5 immunofluorescent staining images of sprayed 
trachea samples at day 8.  
Images at 4x (a,d), 10x (b,e) and 20x (c,f). Images of sprayed trachea sample at day 8 
(a-c) and native porcine trachea used as a positive control (d-f). HBECs show excellent 
staining for CK5, which is similar to the positive control. 
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Figure 3.25 – Representative uteroglobin immunofluorescent staining images of 
sprayed trachea samples at day 8.  
Images of native mouse lung used as positive control (a-b), sprayed trachea sample at 
day 8 (c-e), and samples with secondary antibody only as negative control (f-h). Images 
at 4x (c,f), 10x (a,d,g) and 20x (b,e,h). HBECs show diffuse staining that is similar to the 
positive control and not seen in the negative control.  
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